FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Potassium Acetate Injection
Status: Currently in Shortage
»Date first posted: 06/10/2019
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Expand all

Exela Pharma Sciences, LLC (Revised 05/16/2022)

Company Contact Information:
828-758-5474

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Potassium Acetate Inj. 40mEq (2mEq/ml) 20mL (NDC 51754-2001-4)	Product shipped to and available in wholesalers. Additional shipment end of May 2022. Increased supply available in mid-June.		Demand increase for the drug

Hospira, Inc., a Pfizer company (Revised 03/17/2023)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
100 mEq/50 mL (2 mEq/mL), Pharmacy Bulk Package Glass Fliptop Vial (NDC 0409-3294-51)	Available	Pfizer Customer Letter Dates May 10, 2022	Other
40 mEq/20 mL (2 mEq/mL), Single Dose Plastic Fliptop Vial (NDC 00409-8183-01)	Next Delivery: March 2023; Estimated Recovery: September 2023	Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Pfizer Customer Letter Dates May 10, 2022	Other
100 mEq/50 mL (2 mEq/mL), Pharmacy Bulk Package Glass Fliptop Vial (NDC 0409-3294-25), Novaplus	Limited Supply Available. Next Delivery: June 2023; Estimated Recovery: December 2023	Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay	Other
40 mEq/20 mL (2 mEq/mL), Single Dose Plastic Fliptop Vial (NDC 0409-8183-25), Novaplus	Next Delivery and Estimated Recovery: June 2023	Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay	Other